15717945Desai AA, Stadler WMCurrent oncology reportsAngiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Kidney Neoplasms; Protein Kinase InhibitorsAntibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Clinical Trials as Topic; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Sorafenib; SunitinibNovel kinase inhibitors in renal cell carcinoma: progressive development of static agents. Curr Oncol Rep. 2005 Mar; 7(2):116-22.Curr Oncol Rep2005-03-01T00:00:002005Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD002292Disorders1134250.717085Carcinoma, Renal CellD007680Disorders1406200.652811Kidney NeoplasmsD004791Chemicals & Drugs2686320.779731Enzyme InhibitorsD007211Chemicals & Drugs1343180.849938IndolesAuthorship 265262D010671Chemicals & Drugs511130.945896Phenylurea CompoundsD011725Chemicals & Drugs1533090.839039PyridinesD006801Living Beings2262862810.130052Humans0.2665610.2665611authors10.2518has subject areaD020533Chemicals & DrugsPhysiology1073090.812499Angiogenesis InhibitorsD011758Chemicals & Drugs621840.890788PyrrolesD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD001557Chemicals & Drugs29660.952978BenzenesulfonatesD002986Procedures32811680.665227Clinical Trials as TopicD000068258732810.891431BevacizumabD066246Chemicals & Drugs1494850.779528ErbB ReceptorsD009536Chemicals & Drugs541160.957027NiacinamideD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor